DIVIS Laboratories a leading Indian pharma company is on a high growth path

Divi's Laboratories started operations more than 29 years back in Hyderabad. 

Today Divis is one of the Top 3 API (Active Pharmaceutical Ingredient) manufacturers in the world. Out of the 26 categories of APIs it manufactures it is world leader in 11 of them.

Currently its products are exported to over 95 countries in the world. 

Dr. Murli K Divi is the promoter and Managing director of the company. Prior to starting Divi’s, Dr. Divi had extensive experience of over 15 years in the Pharma industry and has led various Research and Manufacturing teams globally. 

He holds a Ph.D. degree in Pharmaceutical Sciences from Kakatiya University, India. He is also a member of the American Institute of Chemical Engineers and the American Chemical Society.

Divi's has built core strengths are helping it in the current environment.

1. There is renewed growth prospects for generic APIs,
2. Divi's has strong relationship with innovators, which is improving the scope of business in CRAMS (Contract Research And Manufacturing Services), and 
3. Divi's is able to do capex support to meet the future requirements of customers.

The overall outlook for API manufacturers has improved on account of lower supplies from Chinese companies.  This could be attributed to manufacturing issues within Chinese companies or resistance in purchasing from them.

Divi's Laboratories Stock Past one year 

(Source www.nseindia.com)

Divi's Laboratories Stock Past five years 

(Source www.nseindia.com)

Disclaimer : This blog is for information purposes only and not to illicit any business or to make any recomendation of any kind. Stock investing is a with risk investing including risk on the capital invested. Please take am informed decision. Further disclaimers apply, please read at the bottom of this web page.